Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC, 61795 [2017-28178]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Network Centric
Operations Industry Consortium, Inc.
Notice is hereby given that, on
December 5, 2017, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Network Centric Operations Industry
Consortium, Inc. (‘‘NCOIC’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Marc Fiammante (individual member),
Alpes Maritimes, FRANCE, has been
added as a party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NCOIC
intends to file additional written
notifications disclosing all changes in
membership.
On November 19, 2004, NCOIC filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on February 2, 2005 (70
FR 5486).
The last notification was filed with
the Department on July 11, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on August 15, 2017 (82 FR 38711).
comments on or objections to the
issuance of the proposed registration on
or before February 27, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on October
28, 2016, AMPAC Fine Chemicals
Virginia, LLC, 2820 North Normandy
Drive, Petersburg, Virginia 23805–2380
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled
substance
Drug code
Methylphenidate ...
Levomethorphan ...
Levorphanol ..........
1724
9210
9220
Schedule
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Dated: December 15, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–28129 Filed 12–28–17; 8:45 am]
[FR Doc. 2017–28178 Filed 12–28–17; 8:45 am]
BILLING CODE P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
ethrower on DSK3G9T082PROD with NOTICES
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals LLC
Importer of Controlled Substances
Application: ABBVIE LTD; Correction
ACTION:
ACTION:
Notice of application.
VerDate Sep<11>2014
20:09 Dec 28, 2017
Jkt 244001
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register of
December 1, 2017, concerning a notice
SUMMARY:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
DATES:
Notice; correction.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
61795
of application that inadvertently
misstated what the firm plans to do with
imported tapentadol.
Correction
In the Federal Register of December 1,
2017, in FR Doc. 2017–25921 (82 FR
230), on page 230, in the second
column, the last paragraph, correct the
first sentence to read: The company
plans to import bulk tapentadol (9780)
to manufacture dosage form tapentadol
(9780) for distribution to its customers.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–28176 Filed 12–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cambrex
High Point, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 27, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 22, 2016, Cambrex High
Point, Inc., 4180 Mendenhall Oaks
Parkway, High Point, North Carolina
27265 applied to be registered as a bulk
DATES:
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)]
[Notices]
[Page 61795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28178]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: AMPAC
Fine Chemicals LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 27, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
October 28, 2016, AMPAC Fine Chemicals Virginia, LLC, 2820 North
Normandy Drive, Petersburg, Virginia 23805-2380 applied to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methylphenidate...................... 1724 II
Levomethorphan....................... 9210 II
Levorphanol.......................... 9220 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Dated: December 15, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-28178 Filed 12-28-17; 8:45 am]
BILLING CODE 4410-09-P
